41 employees
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.
2017
$17M
from 5 investors over 5 rounds
Empirico Inc. raised $17M on January 9, 2020
Investors: Ionis Pharmaceuticals, Inc., Neotribe Ventures and DCVC Bio
Empirico Inc. raised $13M on November 1, 2018
Investors: Neotribe Ventures and DCVC Bio